Claraphi Advisory Network’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-18,500	Closed	-$335K	–	263
2017 Q4	$335K	Buy	+18,500	New	+$335K	0.26%	116